[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Adrenoleukodystrophy Drugs Market Report 2017

December 2017 | 104 pages | ID: ABB1676DFB8EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Adrenoleukodystrophy Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Adrenoleukodystrophy Drugs for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Adrenoleukodystrophy Drugs market competition by top manufacturers/players, with Adrenoleukodystrophy Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Applied Genetic Technologies Corp
  • Bluebird Bio Inc
  • MedDay SA
  • Minoryx Therapeutics sl
  • Pfizer Inc
  • ReceptoPharm Inc
  • SOM Biotech SL
  • Viking Therapeutics Inc
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Biotin
  • DRX-065
  • DUOC-01
  • Lenti-D
  • MIN-102
  • OP-101
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Children
  • Adult
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Adrenoleukodystrophy Drugs Market Report 2017

1 ADRENOLEUKODYSTROPHY DRUGS OVERVIEW

1.1 Product Overview and Scope of Adrenoleukodystrophy Drugs
1.2 Classification of Adrenoleukodystrophy Drugs by Product Category
  1.2.1 Asia-Pacific Adrenoleukodystrophy Drugs Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Adrenoleukodystrophy Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Biotin
  1.2.4 DRX-065
  1.2.5 DUOC-01
  1.2.6 Lenti-D
  1.2.7 MIN-102
  1.2.8 OP-101
  1.2.9 Others
1.3 Asia-Pacific Adrenoleukodystrophy Drugs Market by Application/End Users
  1.3.1 Asia-Pacific Adrenoleukodystrophy Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Children
  1.3.3 Adult
1.4 Asia-Pacific Adrenoleukodystrophy Drugs Market by Region
  1.4.1 Asia-Pacific Adrenoleukodystrophy Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Adrenoleukodystrophy Drugs (2012-2022)
  1.5.1 Asia-Pacific Adrenoleukodystrophy Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC ADRENOLEUKODYSTROPHY DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Adrenoleukodystrophy Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Adrenoleukodystrophy Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Adrenoleukodystrophy Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific Adrenoleukodystrophy Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Adrenoleukodystrophy Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Adrenoleukodystrophy Drugs (Volume) by Application
2.4 Asia-Pacific Adrenoleukodystrophy Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific Adrenoleukodystrophy Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Adrenoleukodystrophy Drugs Revenue and Market Share by Region (2012-2017)

3 CHINA ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  3.1.1 China Adrenoleukodystrophy Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 China Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
3.2 China Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
3.3 China Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

4 JAPAN ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  4.1.1 Japan Adrenoleukodystrophy Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
4.2 Japan Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
4.3 Japan Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  5.1.1 South Korea Adrenoleukodystrophy Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
5.2 South Korea Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
5.3 South Korea Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

6 TAIWAN ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  6.1.1 Taiwan Adrenoleukodystrophy Drugs Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
6.3 Taiwan Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

7 INDIA ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  7.1.1 India Adrenoleukodystrophy Drugs Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 India Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
7.2 India Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
7.3 India Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  8.1.1 Southeast Asia Adrenoleukodystrophy Drugs Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

9 AUSTRALIA ADRENOLEUKODYSTROPHY DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Adrenoleukodystrophy Drugs Sales and Value (2012-2017)
  9.1.1 Australia Adrenoleukodystrophy Drugs Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Adrenoleukodystrophy Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Adrenoleukodystrophy Drugs Sales Price Trend (2012-2017)
9.2 Australia Adrenoleukodystrophy Drugs Sales Volume and Market Share by Type
9.3 Australia Adrenoleukodystrophy Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC ADRENOLEUKODYSTROPHY DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Applied Genetic Technologies Corp
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Bluebird Bio Inc
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 MedDay SA
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 MedDay SA Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Minoryx Therapeutics sl
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Pfizer Inc
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Pfizer Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 ReceptoPharm Inc
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 SOM Biotech SL
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 SOM Biotech SL Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Viking Therapeutics Inc
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Adrenoleukodystrophy Drugs Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview

11 ADRENOLEUKODYSTROPHY DRUGS MANUFACTURING COST ANALYSIS

11.1 Adrenoleukodystrophy Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Adrenoleukodystrophy Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Adrenoleukodystrophy Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Adrenoleukodystrophy Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC ADRENOLEUKODYSTROPHY DRUGS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Adrenoleukodystrophy Drugs Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Adrenoleukodystrophy Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Adrenoleukodystrophy Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Adrenoleukodystrophy Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Adrenoleukodystrophy Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Adrenoleukodystrophy Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Adrenoleukodystrophy Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Adrenoleukodystrophy Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Adrenoleukodystrophy Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Adrenoleukodystrophy Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Adrenoleukodystrophy Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Adrenoleukodystrophy Drugs Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Adrenoleukodystrophy Drugs Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Adrenoleukodystrophy Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Adrenoleukodystrophy Drugs Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Adrenoleukodystrophy Drugs
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Biotin Product Picture
Figure DRX-065 Product Picture
Figure DUOC-01 Product Picture
Figure Lenti-D Product Picture
Figure MIN-102 Product Picture
Figure OP-101 Product Picture
Figure Others Product Picture
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Adrenoleukodystrophy Drugs by Application in 2016
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adult Examples
Table Key Downstream Customer in Adult
Figure Asia-Pacific Adrenoleukodystrophy Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific Adrenoleukodystrophy Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Adrenoleukodystrophy Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Adrenoleukodystrophy Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Adrenoleukodystrophy Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Adrenoleukodystrophy Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Adrenoleukodystrophy Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Adrenoleukodystrophy Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Adrenoleukodystrophy Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Adrenoleukodystrophy Drugs Revenue Share by Players
Table Asia-Pacific Adrenoleukodystrophy Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Adrenoleukodystrophy Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Adrenoleukodystrophy Drugs by Type (2012-2017)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Adrenoleukodystrophy Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Adrenoleukodystrophy Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Adrenoleukodystrophy Drugs by Type (2012-2017)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific Adrenoleukodystrophy Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Adrenoleukodystrophy Drugs by Region (2012-2017)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Adrenoleukodystrophy Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Adrenoleukodystrophy Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Adrenoleukodystrophy Drugs by Region (2012-2017)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific Adrenoleukodystrophy Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales Market Share by Application (2012-2017)
Figure China Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table China Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table China Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table China Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table China Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Figure Japan Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table Japan Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table South Korea Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Figure India Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table India Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table India Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table India Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table India Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Figure Australia Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Australia Adrenoleukodystrophy Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Adrenoleukodystrophy Drugs Sales Volume Market Share by Type in 2016
Table Australia Adrenoleukodystrophy Drugs Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia Adrenoleukodystrophy Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Adrenoleukodystrophy Drugs Sales Volume Market Share by Application in 2016
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Basic Information List
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Basic Information List
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Bluebird Bio Inc Adrenoleukodystrophy Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table MedDay SA Adrenoleukodystrophy Drugs Basic Information List
Table MedDay SA Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MedDay SA Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure MedDay SA Adrenoleukodystrophy Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure MedDay SA Adrenoleukodystrophy Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Basic Information List
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Inc Adrenoleukodystrophy Drugs Basic Information List
Table Pfizer Inc Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Inc Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Inc Adrenoleukodystrophy Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Inc Adrenoleukodystrophy Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Basic Information List
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure ReceptoPharm Inc Adrenoleukodystrophy Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table SOM Biotech SL Adrenoleukodystrophy Drugs Basic Information List
Table SOM Biotech SL Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure SOM Biotech SL Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure SOM Biotech SL Adrenoleukodystrophy Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure SOM Biotech SL Adrenoleukodystrophy Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Basic Information List
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Viking Therapeutics Inc Adrenoleukodystrophy Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adrenoleukodystrophy Drugs
Figure Manufacturing Process Analysis of Adrenoleukodystrophy Drugs
Figure Adrenoleukodystrophy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Adrenoleukodystrophy Drugs Major Manufacturers in 2016
Table Major Buyers of Adrenoleukodystrophy Drugs
Table Distributors/Traders List
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Adrenoleukodystrophy Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Revenue Market Share Forecast by Region in 2022
Figure China Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Adrenoleukodystrophy Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia Adrenoleukodystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Adrenoleukodystrophy Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Adrenoleukodystrophy Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Adrenoleukodystrophy Drugs Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific Adrenoleukodystrophy Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific Adrenoleukodystrophy Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories